NCAM1 and graft versus host disease: To further evaluate the diagnostic value of the CD56+:CD3+ ratio for GVHD, we performed receiver operating characteristic curve analysis to compare the GVHD and non-GVHD groups (the latter comprising iTAM, cytomegalovirus, and nonspecific inflammation).